L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function

BACKGROUND: There are an increasing number of patients suffering from fatty liver caused by type 2 diabetes. We intended to study the preventive and therapeutic effect of L-carnitine (LC) on nonalcoholic fatty liver disease (NAFLD) in streptozotocin (STZ)-induced type 2 diabetic mice and to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yunqiu, Li, Qing, Zhong, Weizhen, Dong, Jing, Wang, Zhulin, Wang, Chunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226540/
https://www.ncbi.nlm.nih.gov/pubmed/22082204
http://dx.doi.org/10.1186/1758-5996-3-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226540/
https://www.ncbi.nlm.nih.gov/pubmed/22082204
http://dx.doi.org/10.1186/1758-5996-3-31

Ejemplares similares